Hepatitis B-related hepatocellular carcinoma: Epidemiological characteristics and disease burden

Journal of Viral Hepatitis

Volumn 16, Issue 7, 2009, Pages 453-463

  Nguyen, V T T ^a   Law, M G ^b   Dore, G J ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Epidemiology; Hepatitis B virus; Hepatocellular carcinoma; Liver disease burden; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ANTIVIRUS AGENT; CORE PROTEIN; HEPATITIS B VACCINE; VIRUS DNA;

AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CANCER SURVIVAL; CHRONIC HEPATITIS; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MUTATION; GENOTYPE; HEALTH CARE COST; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RATE; INFECTION RISK; LIFESTYLE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PUBLIC HEALTH PROBLEM; REVIEW; SEX DIFFERENCE; SMOKING HABIT; SURVIVAL RATE; TREATMENT PLANNING; VACCINATION; VIRUS CARCINOGENESIS; VIRUS DIAGNOSIS;

CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; MALE; PROGNOSIS; RISK FACTORS;

EID: 67650469737     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01117.x     Document Type: Review

References (110)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001 2 (9 533 543. (Pubitemid 33586866)
2. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF. International trends and patterns of primary liver cancer. Int J Cancer 2001 94 (2 290 296. (Pubitemid 32911426)
3. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004 127 (5 S5 S16.
4. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005 19 (1 3 23. (Pubitemid 40331495)
5. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003 362 (9399 1907 1917. (Pubitemid 37518510)
6. Yeung YP, Lo CM, Liu CL, Wong BC, Fan ST, Wong J. Natural history of untreated nonsurgical hepatocellular carcinoma. Am J Gastroenterol 2005 100 (9 1995 2004. (Pubitemid 43919392)
7. Nguyen VTT, Amin J, Law M, Dore G. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia. J Gastroenterol Hepatol 2008 early view article doi :.
8. Barazani Y, Hiatt J, Tong M, Busuttil R. Chronic viral hepatitis and hepatocellular carcinoma. World J Surg 2007 31 (6 1245 1250.
9. Sherman M, Peltekian K, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis virus: incidence and prevalence of hepatocellular carcinoma and liver cirrhosis in a North American urban population. Hepatology 1995 22 : 432 448.
10. Blumberg BS, Larouze B, London WT et al. The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol 1975 81 (3 669 682.
11. Maupas P, Larouze B, London WT et al. Antibody to hepatitis B core antigen in patients with primary hepatic carcinoma. Lancet 1975 306 (7923 9 11.
12. Anzola M. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 2004 11 (5 383 393. (Pubitemid 39336219)
13. Park NH, Song IH, Chung YH. Chronic hepatitis B in hepatocarcinogenesis. Postgrad Med J 2006 82 (970 507 515. (Pubitemid 44258625)
14. Lok ASF. Prevention of hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 2004 127 (5 S303 S309.
15. Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004 127 (5 Suppl 1 S56 S61.
16. Bréchot C, Gozuacik D, Murakami Y, Paterlini-Bréchot P. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin Cancer Biol 2000 10 (3 211 231. (Pubitemid 30614221)
17. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "occult"? Hepatology 2001 34 (1 194 203. (Pubitemid 32591500)
18. Lee WM. Hepatitis B virus infection. N Engl J Med 1997 337 (24 1733 1745. (Pubitemid 27527771)
19. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000 64 (1 51 68. (Pubitemid 30143840)
20. Gelatti U, Donato F, Tagger A et al. Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. Am J Gastroenterol 2003 98 (4 907 914. (Pubitemid 36576322)
21. Villa E, Baldini GM, Pasquinelli C et al. Risk factors for hepatocellular carcinoma in italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol. Cancer 1988 62 (3 611 615. (Pubitemid 18176748)
22. Crook PD, Jones ME, Hall AJ. Mortality of hepatitis B surface antigen-positive blood donors in England and Wales. Int J Epidemiol 2003 32 (1 118 124. (Pubitemid 36503487)
23. Yang H-I, Lu S-N, Liaw Y-F et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002 347 (3 168 174. (Pubitemid 34764820)
24. Sun C-A, Wu D-M, Lin C-C et al. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol 2003 157 (8 674 682. (Pubitemid 36423080)
25. Chen C-J, Yang H-I, Su J et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006 295 (1 65 73. (Pubitemid 43042691)
26. Xu B, Hu D-C, Rosenberg DM et al. Chronic hepatitis B: a long-term retrospective cohort study of disease progression in Shanghai, China. J Gastroenterol Hepatol 2003 18 (12 1345 1352. (Pubitemid 38045846)
27. Beasley R. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988 61 (10 1942 1956. (Pubitemid 18123472)
28. Wang LY, You SL, Lu SN et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 2003 14 (3 241 250.
29. Chen C-L, Yang H-I, Yang W-S et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008 135 (1 111 121.
30. Yu M-W, Yeh S-H, Chen P-J et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005 97 (4 265 272. (Pubitemid 40310274)
31. Yuen M-F, Sablon E, Yuan H-J et al. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma. Hepatology 2003 37 (3 562 567. (Pubitemid 36258778)
32. Toan NL, Song LH, Kremsner PG et al. Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology 2006 43 (6 1375 1384. (Pubitemid 43982515)
33. Kobayashi M, Akuta N, Suzuki F et al. Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and C. J Med Virol 2006 78 (1 60 67. (Pubitemid 41783844)
34. Wu C-F, Yu M-W, Lin C-L et al. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis 2008 29 (1 106 112. (Pubitemid 351201748)
35. Livingston S, Simonetti J, McMahon B et al. Hepatitis B virus genotypes in Alaska native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 2007 195 (1 5 11. (Pubitemid 44958221)
36. Donato F, Boffetta B, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998 75 (3 347 354. (Pubitemid 28100034)
37. Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005 92 (3 607 612. (Pubitemid 40395547)
38. Park BK, Park YN, Ahn SH et al. Long-term outcome of chronic hepatitis B based on histological grade and stage. J Gastroenterol Hepatol 2007 22 (3 383 388. (Pubitemid 46238769)
39. Yu M-W, Hsu F-C, Sheen IS et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997 145 (11 1039 1047. (Pubitemid 27215487)
40. Lok AS. Occult hepatitis & nbsp; B virus infection: diagnosis, implications and management? J Gastroenterol Hepatol 2004 19 (s7 S114 S117.
41. Yuen M-F, Wong DK-H, Fung J et al. HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 2008 135 (4 1192 1199.
42. Donato F, Tagger A, Gelatti U et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002 155 (4 323 331. (Pubitemid 34132050)
43. Donato F, Tagger A, Chiesa R et al. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Hepatology 1997 26 (3 579 584. (Pubitemid 27392347)
44. Hassan MM, Hwang L-Y, Hatten CJ et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002 36 (5 1206 1213. (Pubitemid 35253437)
45. Chen C-J, Liang K-Y, Chang A-S et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991 13 (3 398 406.
46. Okuda K, Ohtsuki T, Obata H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients. Cancer 1985 56 (4 918 928. (Pubitemid 15228292)
47. Lam CM, Chan AOO, Ho P et al. Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening. Aliment Pharmacol Ther 2004 19 (7 771 777. (Pubitemid 38496643)
48. Chen C-H, Huang G-T, Yang P-M et al. Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis. Eur J Cancer 2006 42 (15 2524 2529. (Pubitemid 44442947)
49. Pawarode A, Tangkijvanich P, Voravud N. Outcomes of primary hepatocellular carcinoma treatment: an 8-year experience with 368 patients in Thailand. J Gastroenterol Hepatol 2000 15 (8 860 864. (Pubitemid 30744909)
50. Lerose R, Molinari R, Rocchi E, Manenti F, Villa E. Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. Eur J Cancer 2001 37 (2 239 245. (Pubitemid 32144702)
51. El-Serag HB, Siegel AB, Davila JA et al. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol 2006 44 (1 158 166. (Pubitemid 41772530)
52. Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol 2007 102 (8 1661 1670. (Pubitemid 47206702)
53. Wong LL, Limm WM, Tsai N, Severino R. Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients. World J Gastroenterol 2005 11 (23 3491 3497. (Pubitemid 40903499)
54. Perry JF, Charlton B, Koorey DJ et al. Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver Int 2007 27 (9 1240 1248. (Pubitemid 47543153)
55. Villa E, Moles A, Paola IF et al. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology 2000 32 (2 233 238. (Pubitemid 30614655)
56. Park KW, Park J-W, Choi JI et al. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol 2008 23 : 467 473. (Pubitemid 351342066)
57. Trevisani F, Magini G, Santi V et al. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. Am J Gastroenterol 2007 102 (5 1022 1031. (Pubitemid 46698223)
58. Tanizaki H, Ryu M, Kinoshita T et al. Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma. Jpn J Clin Oncol 1997 27 (2 67 70. (Pubitemid 127518571)
59. Cantarini MC, Trevisani F, Morselli-Labate AM et al. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma. Am J Gastroenterol 2006 101 (1 91 98. (Pubitemid 43381714)
60. El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 2001 33 (1 62 65. (Pubitemid 32016888)
61. Chen C-H, Su W-W, Yang S-S et al. Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11 312 patients in Taiwan. J Gastroenterol Hepatol 2006 21 (10 1561 1566. (Pubitemid 44266515)
62. Rabe C, Pilz T, Klostermann C et al. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001 7 (2 208 215. (Pubitemid 32377472)
63. WHO. Hepatitis B, Fact sheet N°204. Revised August 2008 Geneva : WHO. [Online] [cited 1/10/2008]. Available from: http://www.who.int/mediacentre/ factsheets/fs204/en/index.html
64. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006 118 (12 3030 3044.
65. Amin J, O'Connell D, Bartlett M et al. Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study. Aust N Z J Public Health 2007 31 (5 475 482. (Pubitemid 47629025)
66. Law MG, Roberts SK, Dore GJ, Kaldor JM. Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med J Aust 2000 173 (8 403 405. (Pubitemid 30786065)
67. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003 139 (10 817 823.
68. Remontet L, Esteve J, Bouvier AM et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003 51 (1 Pt 1 3 30. (Pubitemid 36813955)
69. Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006 45 (4 529 538. (Pubitemid 44307383)
70. Beutels P, Musabaev EI, Van Damme P, Yasin T. The disease burden of hepatitis B in Uzbekistan. J Infect 2000 40 (3 234.
71. Nguyen VTT, Razali K, Amin J, Law MG, Dore GJ. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries. J Gastroenterol Hepatol 2008 23 : 922 929. (Pubitemid 351806566)
72. Nguyen VTT, Law MG, Dore GJ. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int 2008 28 (4 525 531.
73. Idris BI, Brosa M, Richardus JH, Esteban R, Schalm SW, Buti M. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain. Eur J Gastroenterol Hepatol 2008 20 (4 320 326.
74. Butler JRG, Pianko S, Korda RJ et al. The direct cost of managing patients with chronic hepatitis B infection in Australia. J Clin Gastroenterol 2004 38 (10 S187 S192.
75. Yang BM, Paik SW, Hahn OS, Yi DH, Choi MS, Payne S. Economic evaluation of the societal costs of hepatitis B in South Korea. J Gastroenterol Hepatol 2001 16 (3 301 308. (Pubitemid 32374846)
76. Mori M, Hara M, Wada I et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000 151 (2 131 139. (Pubitemid 30463643)
77. Sakuma K, Saitoh N, Kasai M et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study. Hepatology 1988 8 (6 1642 1646. (Pubitemid 19021901)
78. Harris R, Chen G, Lin W, Shen F, London WT, Evans A. Spontaneous clearance of high-titer serum HBV DNA and risk of hepatocellular carcinoma in a Chinese population. Cancer Causes Control 2003 14 (10 995 1000. (Pubitemid 38091220)
79. Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004 96 (24 1851 1856. (Pubitemid 40081322)
80. Lee M-S, Kim D-H, Kim H et al. Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea. Int J Epidemiol 1998 27 (2 316 319. (Pubitemid 28203802)
81. Yood MU, Quesenberry CP, Guo D et al. Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm. J Viral Hepat 2008 15 (1 28 36. (Pubitemid 350243580)
82. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 2001 135 (9 759 768. (Pubitemid 33051260)
83. Amin J, Dore GJ, O'Connell DL et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006 45 (2 197 203.
84. Tagger A, Donato F, Ribero ML et al. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Int J Cancer 1999 81 (5 695 699. (Pubitemid 29214375)
85. Kuper HE, Tzonou A, Kaklamani E et al. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays. Cancer Causes Control 2000 11 (2 171 175. (Pubitemid 30088397)
86. Lu SN, Lin TM, Chen CJ et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988 62 (9 2051 2055. (Pubitemid 18261836)
87. Yu M-W, You S-L, Chang A-S, Lu S-N, Liaw Y-F, Chen C-J. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991 51 (20 5621 5625.
88. Qian GS, Ross RK, Yu MC et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994 3 (1 3 10. (Pubitemid 24172514)
89. Chuang W-L, Chang W-Y, Lu S-N et al. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer 1992 69 (8 2052 2054.
90. Sharp GB, Lagarde F, Mizuno T et al. Relationship of hepatocellular carcinoma to soya food consumption: a cohort-based, case-control study in Japan. Int J Cancer 2005 115 (2 290 295. (Pubitemid 40586739)
91. Kumar M, Kumar R, Hissar SS et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007 22 (7 1104 1111. (Pubitemid 47019860)
92. Omer RE, Veer PV, Kadaru AMY et al. The role of hepatitis B and hepatitis C viral infections in the incidence of hepatocellular carcinoma in Sudan. Trans R Soc Trop Med Hyg 2001 95 (5 487 491. (Pubitemid 34947400)
93. Iloeje UH, Yang H-I, Jen C-L et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol 2007 5 (8 921 931. (Pubitemid 47161142)
94. Chen C-H, Chen YY, Chen G-H et al. Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma. J Hepatol 2004 40 (4 653 659. (Pubitemid 38367788)
95. Evans AA, Chen G, Ross EA, Shen F-M, Lin W-Y, London WT. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 2002 11 (4 369 376. (Pubitemid 34408216)
96. Liu C-J, Chen B-F, Chen P-J et al. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J Infect Dis 2006 193 (9 1258 1265.
97. Tsai FC, Liu CJ, Chen CL et al. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma. J Viral Hepat 2006 14 (0 153 160.
98. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004 1 : S35 S50.
99. Ohata K, Hamasaki K, Toriyama KAN, Ishikawa H, Nakao K, Eguchi K. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 2004 19 (6 670 675. (Pubitemid 38858201)
100. Mahmood S, Niiyama G, Kamei A et al. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma. Liver Int 2005 25 (2 220 225.
101. Beasley P, Hwang L-L. Epidemiology of hepatocellular carcinoma. Viral hepatitis and liver disease. Orlando : Grune & Stratton, 1984 : 209224.
102. Yuan HJ, Yuen MF, Ka-Ho Wong D, Sablon E, Lai CL. The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B. J Viral Hepat 2005 12 (4 373 379. (Pubitemid 40961476)
103. Tang B, Kruger WD, Chen G et al. Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers. J Med Virol 2004 72 (1 35 40. (Pubitemid 37484740)
104. Ishikawa T, Ichida T, Yamagiwa S et al. High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis. J Gastroenterol Hepatol 2001 16 (11 1274 1281. (Pubitemid 34088276)
105. Ikeda K, Saitoh S, Suzuki Y et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 1998 28 (6 930 938. (Pubitemid 28275969)
106. Yu MC, Yuan J-M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004 127 : S72 S78.
107. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997 12 (9-10 S294 S308.
108. Schoniger-Hekele M, Muller C, Kutilek M, Oesterreicher C, Ferenci P, Gangl A. Hepatocellular carcinoma in Central Europe: prognostic features and survival. (Statistical Data Included). Gut 2001 48 (1 103.
109. Yaghi C, Sharara A-I, Rassam P et al. Hepatocellular carcinoma in Lebanon: etiology and prognostic factors associated with short-term survival. World J Gastroenterol 2006 12 (22 3575 3580. (Pubitemid 43997034)
110. Llovet JM, Bustamante J, Castells A et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999 29 (1 62 67. (Pubitemid 29023987)